T. Rowe Price Associates’s Medicines Co MDCO Stock Holding History

T. Rowe Price Associates’s Portfolio MDCO Stock Details MDCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-43,958	Closed	-$3.73M	–	2605
2019 Q4	$3.73M	Sell	43,958 -15,544	-26%	-$1.32M	﹤0.01%	1453
2019 Q3	$2.98M	Sell	59,502 -1,733	-3%	-$86.6K	﹤0.01%	1472
2019 Q2	$2.23M	Buy	61,235 +2,785	+5%	+$102K	﹤0.01%	1566
2019 Q1	$1.63M	Buy	58,450 +9,000	+18%	+$252K	﹤0.01%	1649
2018 Q4	$946K	Sell	49,450 -11,683	-19%	-$224K	﹤0.01%	1814
2018 Q3	$1.83M	Buy	61,133 +225	+0.4%	+$6.73K	﹤0.01%	1650
2018 Q2	$2.24M	Sell	60,908 -8,173	-12%	-$300K	﹤0.01%	1568
2018 Q1	$2.28M	Sell	69,081 -7,645	-10%	-$252K	﹤0.01%	1541
2017 Q4	$2.1M	Sell	76,726 -243,297	-76%	-$6.65M	﹤0.01%	1557
2017 Q3	$11.9M	Buy	320,023 +25,502	+9%	+$945K	﹤0.01%	1299
2017 Q2	$11.2M	Sell	294,521 -1,095,625	-79%	-$41.6M	﹤0.01%	1301
2017 Q1	$68M	Sell	1,390,146 -58,310	-4%	-$2.85M	0.01%	707
2016 Q4	$49.2M	Sell	1,448,456 -13,630	-0.9%	-$463K	0.01%	813
2016 Q3	$55.2M	Buy	1,462,086 +13,586	+0.9%	+$513K	0.01%	774
2016 Q2	$48.7M	Buy	1,448,500 +1,660	+0.1%	+$55.8K	0.01%	793
2016 Q1	$46M	Sell	1,446,840 -10,730	-0.7%	-$341K	0.01%	798
2015 Q4	$54.4M	Sell	1,457,570 -1,500	-0.1%	-$56K	0.01%	736
2015 Q3	$55.4M	Sell	1,459,070 -2,263,035	-61%	-$85.9M	0.01%	740
2015 Q2	$106M	Sell	3,722,105 -123,800	-3%	-$3.54M	0.02%	583
2015 Q1	$108M	Sell	3,845,905 -42,720	-1%	-$1.2M	0.02%	586
2014 Q4	$108M	Buy	3,888,625 +13,700	+0.4%	+$379K	0.02%	597
2014 Q3	$86.5M	Sell	3,874,925 -7,100	-0.2%	-$158K	0.02%	650
2014 Q2	$113M	Sell	3,882,025 -1,715,270	-31%	-$49.8M	0.02%	602
2014 Q1	$159M	Sell	5,597,295 -244,420	-4%	-$6.95M	0.04%	491
2013 Q4	$226M	Sell	5,841,715 -76,610	-1%	-$2.96M	0.05%	401
2013 Q3	$198M	Buy	5,918,325 +166,230	+3%	+$5.57M	0.05%	402
2013 Q2	$177M	Buy	+5,752,095	New	+$177M	0.05%	421